KAHN BROTHERS GROUP INC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,113 filers reported holding NOVARTIS A G in Q2 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
KAHN BROTHERS GROUP INC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$2,198,232
+1.0%
21,5780.0%0.34%
+7.5%
Q2 2023$2,177,092
+9.7%
21,5780.0%0.32%
+11.5%
Q1 2023$1,985,400
+1.4%
21,5780.0%0.29%
+10.9%
Q4 2022$1,957,864
-99.9%
21,578
-6.5%
0.26%
-5.5%
Q3 2022$1,754,212,000
-10.1%
23,0780.0%0.27%
+3.8%
Q2 2022$1,950,436,000
-0.7%
23,078
+3.1%
0.26%
+5.6%
Q1 2022$1,964,000,000
+0.3%
22,3780.0%0.25%
-7.4%
Q4 2021$1,957,403,000
+17.3%
22,378
+9.7%
0.27%
+14.5%
Q3 2021$1,668,148,000
-10.4%
20,3980.0%0.24%
-12.0%
Q2 2021$1,861,114,000
+6.7%
20,3980.0%0.27%
-1.1%
Q1 2021$1,743,621,000
-17.6%
20,398
-8.9%
0.27%
-26.8%
Q4 2020$2,115,043,000
+7.2%
22,398
-1.3%
0.37%
-1.3%
Q3 2020$1,973,818,000
-0.4%
22,6980.0%0.37%
+11.6%
Q2 2020$1,982,443,000
+3.6%
22,698
-2.2%
0.34%
-4.3%
Q1 2020$1,912,675,000
-21.6%
23,198
-10.0%
0.35%
+18.2%
Q4 2019$2,440,445,000
+9.0%
25,7730.0%0.30%
+5.3%
Q3 2019$2,239,674,000
-4.8%
25,7730.0%0.28%
-4.4%
Q2 2019$2,353,333,000
+7.6%
25,773
+13.3%
0.29%
-14.0%
Q1 2019$2,186,608,000
+12.0%
22,7440.0%0.34%
-2.8%
Q4 2018$1,951,663,000
-2.4%
22,744
-2.0%
0.35%
+14.7%
Q3 2018$1,999,774,000
+14.1%
23,2100.0%0.31%
+10.0%
Q2 2018$1,753,283,000
-1.5%
23,210
+5.5%
0.28%
-1.4%
Q1 2018$1,779,509,000
-20.4%
22,010
-17.3%
0.28%
-19.4%
Q4 2017$2,234,176,000
-0.5%
26,610
+1.8%
0.35%
+2.3%
Q3 2017$2,244,462,000
+2.6%
26,144
-0.3%
0.34%
+2.7%
Q2 2017$2,187,832,000
+5.5%
26,211
-6.1%
0.33%
-6.4%
Q1 2017$2,072,950,000
+5.1%
27,911
+3.1%
0.36%
+7.2%
Q4 2016$1,971,852,000
-9.7%
27,071
-2.1%
0.33%
-15.7%
Q3 2016$2,182,691,000
-4.3%
27,6430.0%0.40%
-10.6%
Q2 2016$2,280,824,000
+13.9%
27,6430.0%0.44%
+17.9%
Q1 2016$2,002,459,000
-15.8%
27,6430.0%0.38%
-11.8%
Q4 2015$2,378,404,000
-9.3%
27,643
-3.2%
0.42%
-12.6%
Q3 2015$2,623,673,000
-5.2%
28,543
+1.4%
0.49%
+4.1%
Q2 2015$2,767,583,000
-9.4%
28,143
-9.1%
0.47%
-9.5%
Q1 2015$3,053,754,000
+6.4%
30,9680.0%0.52%
+4.2%
Q4 2014$2,869,495,000
+0.4%
30,968
+2.0%
0.50%
+6.5%
Q3 2014$2,858,540,000
+19.7%
30,368
+15.2%
0.46%
+34.0%
Q2 2014$2,387,095,000
+0.0%
26,368
-6.1%
0.35%
+1.8%
Q1 2014$2,386,341,000
+8.5%
28,068
+2.6%
0.34%
-10.0%
Q4 2013$2,199,839,000
-2.4%
27,368
-6.8%
0.38%
+15.5%
Q3 2013$2,252,819,000
+4.9%
29,368
-3.3%
0.33%
-0.9%
Q2 2013$2,147,321,00030,3680.33%
Other shareholders
NOVARTIS A G shareholders Q2 2021
NameSharesValueWeighting ↓
Newman Dignan & Sheerar, Inc. 3,739$353,074,00056.77%
Susquehanna International Securities, Ltd. 118,837$11,222,0008.15%
MANAGED ASSET PORTFOLIOS, LLC 336,762$31,800,0005.59%
Martin Investment Management, LLC 169,019$15,960,0005.10%
SCHARF INVESTMENTS, LLC 1,197,539$113,083,0004.26%
GARLAND CAPITAL MANAGEMENT INC 50,705$4,788,0004.06%
Mawer Investment Management Ltd. 6,625,594$625,655,0003.69%
SPHERA FUNDS MANAGEMENT LTD. 429,000$40,510,0003.60%
First Fiduciary Investment Counsel, Inc. 196,693$18,574,0003.48%
PROFESSIONAL ADVISORY SERVICES INC 227,971$21,527,0003.46%
View complete list of NOVARTIS A G shareholders